Titre : Stimulation transcrânienne par courant continu

Stimulation transcrânienne par courant continu : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Stimulation transcrânienne par courant continu : Questions médicales les plus fréquentes", "headline": "Stimulation transcrânienne par courant continu : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Stimulation transcrânienne par courant continu : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-31", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Stimulation transcrânienne par courant continu" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Électrochoc", "url": "https://questionsmedicales.fr/mesh/D004597", "about": { "@type": "MedicalCondition", "name": "Électrochoc", "code": { "@type": "MedicalCode", "code": "D004597", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.669.224" } } }, "about": { "@type": "MedicalCondition", "name": "Stimulation transcrânienne par courant continu", "alternateName": "Transcranial Direct Current Stimulation", "code": { "@type": "MedicalCode", "code": "D065908", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Marom Bikson", "url": "https://questionsmedicales.fr/author/Marom%20Bikson", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Engineering, The City College of New York." } }, { "@type": "Person", "name": "Christoph Nissen", "url": "https://questionsmedicales.fr/author/Christoph%20Nissen", "affiliation": { "@type": "Organization", "name": "University Hospital of Psychiatry and Psychotherapy, University Psychiatric Services, Bern, Switzerland; Clinic for Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany." } }, { "@type": "Person", "name": "Liciane Fernandes Medeiros", "url": "https://questionsmedicales.fr/author/Liciane%20Fernandes%20Medeiros", "affiliation": { "@type": "Organization", "name": "Laboratório de Farmacologia da Dor e Neuromodulação, Investigações Pré-Clínicas, Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil." } }, { "@type": "Person", "name": "Wolnei Caumo", "url": "https://questionsmedicales.fr/author/Wolnei%20Caumo", "affiliation": { "@type": "Organization", "name": "Programa de Pós-Graduação em Medicina: Ciências Médicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil." } }, { "@type": "Person", "name": "Daniel M Blumberger", "url": "https://questionsmedicales.fr/author/Daniel%20M%20Blumberger", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Long-term outcomes after NORSE: Treatment with vagus nerve stimulation.", "datePublished": "2022-10-09", "url": "https://questionsmedicales.fr/article/36177520", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/epi4.12654" } }, { "@type": "ScholarlyArticle", "name": "Poisoning with central stimulant drugs: an observational study from Oslo, Norway.", "datePublished": "2022-09-29", "url": "https://questionsmedicales.fr/article/36175843", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12245-022-00457-x" } }, { "@type": "ScholarlyArticle", "name": "Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke.", "datePublished": "2022-09-28", "url": "https://questionsmedicales.fr/article/36169558", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD011968.pub4" } }, { "@type": "ScholarlyArticle", "name": "Photobiomodulation at 830 nm Stimulates Migration, Survival and Proliferation of Fibroblast Cells.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36172056", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/DMSO.S374649" } }, { "@type": "ScholarlyArticle", "name": "Multichannel stimulation module as a tool for animal studies on cortical neural prostheses.", "datePublished": "2022-09-13", "url": "https://questionsmedicales.fr/article/36176924", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fmedt.2022.927581" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines et activités comportementales", "item": "https://questionsmedicales.fr/mesh/D004191" }, { "@type": "ListItem", "position": 3, "name": "Techniques psychologiques", "item": "https://questionsmedicales.fr/mesh/D011580" }, { "@type": "ListItem", "position": 4, "name": "Électrochoc", "item": "https://questionsmedicales.fr/mesh/D004597" }, { "@type": "ListItem", "position": 5, "name": "Stimulation transcrânienne par courant continu", "item": "https://questionsmedicales.fr/mesh/D065908" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Stimulation transcrânienne par courant continu - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Stimulation transcrânienne par courant continu", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-29", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Stimulation transcrânienne par courant continu", "description": "Comment évaluer l'efficacité de la tDCS ?\nQuels critères diagnostiques pour la tDCS ?\nLa tDCS est-elle utilisée pour des troubles spécifiques ?\nQuels tests précèdent une séance de tDCS ?\nLa tDCS nécessite-t-elle un diagnostic préalable ?", "url": "https://questionsmedicales.fr/mesh/D065908?page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Stimulation transcrânienne par courant continu", "description": "Quels symptômes la tDCS peut-elle soulager ?\nY a-t-il des effets secondaires notables ?\nLa tDCS affecte-t-elle la mémoire ?\nQuels changements comportementaux peuvent survenir ?\nLa tDCS peut-elle induire des effets cognitifs ?", "url": "https://questionsmedicales.fr/mesh/D065908?page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Stimulation transcrânienne par courant continu", "description": "La tDCS peut-elle prévenir des troubles mentaux ?\nQuels modes de vie favorisent l'efficacité de la tDCS ?\nY a-t-il des recommandations avant la tDCS ?\nLa tDCS nécessite-t-elle une préparation spéciale ?\nComment maintenir les effets de la tDCS ?", "url": "https://questionsmedicales.fr/mesh/D065908?page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Stimulation transcrânienne par courant continu", "description": "Comment se déroule une séance de tDCS ?\nÀ quelle fréquence la tDCS est-elle administrée ?\nLa tDCS est-elle combinée à d'autres traitements ?\nQuels sont les objectifs du traitement par tDCS ?\nLa tDCS est-elle efficace pour tous ?", "url": "https://questionsmedicales.fr/mesh/D065908?page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Stimulation transcrânienne par courant continu", "description": "Quelles complications peuvent survenir avec la tDCS ?\nLa tDCS peut-elle aggraver des conditions existantes ?\nQuels signes doivent alerter après une séance ?\nLa tDCS est-elle sans risque pour tous ?\nComment gérer les effets indésirables de la tDCS ?", "url": "https://questionsmedicales.fr/mesh/D065908?page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Stimulation transcrânienne par courant continu", "description": "Quels facteurs augmentent les risques de tDCS ?\nL'âge influence-t-il l'efficacité de la tDCS ?\nLes médicaments affectent-ils la tDCS ?\nLe stress impacte-t-il la tDCS ?\nY a-t-il des prédispositions génétiques ?", "url": "https://questionsmedicales.fr/mesh/D065908?page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité de la tDCS ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité de la tDCS peut être évaluée par des tests neuropsychologiques et des mesures d'imagerie cérébrale." } }, { "@type": "Question", "name": "Quels critères diagnostiques pour la tDCS ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de critères diagnostiques spécifiques, mais des évaluations cliniques sont nécessaires." } }, { "@type": "Question", "name": "La tDCS est-elle utilisée pour des troubles spécifiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour traiter la dépression, l'anxiété et les troubles cognitifs." } }, { "@type": "Question", "name": "Quels tests précèdent une séance de tDCS ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations neurologiques et psychologiques sont souvent réalisées avant la tDCS." } }, { "@type": "Question", "name": "La tDCS nécessite-t-elle un diagnostic préalable ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic préalable n'est pas toujours nécessaire, mais il est recommandé pour une utilisation ciblée." } }, { "@type": "Question", "name": "Quels symptômes la tDCS peut-elle soulager ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "La tDCS peut soulager des symptômes de dépression, d'anxiété et de douleur chronique." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires notables ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des démangeaisons, des picotements ou des maux de tête." } }, { "@type": "Question", "name": "La tDCS affecte-t-elle la mémoire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut améliorer la mémoire dans certains cas, mais les résultats varient selon les individus." } }, { "@type": "Question", "name": "Quels changements comportementaux peuvent survenir ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des changements d'humeur et d'attention peuvent être observés après la tDCS." } }, { "@type": "Question", "name": "La tDCS peut-elle induire des effets cognitifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut induire des effets cognitifs positifs, comme une meilleure concentration." } }, { "@type": "Question", "name": "La tDCS peut-elle prévenir des troubles mentaux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elle est explorée comme méthode préventive, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Quels modes de vie favorisent l'efficacité de la tDCS ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant exercice et alimentation équilibrée, peut favoriser l'efficacité." } }, { "@type": "Question", "name": "Y a-t-il des recommandations avant la tDCS ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé d'éviter l'alcool et les stimulants avant une séance de tDCS." } }, { "@type": "Question", "name": "La tDCS nécessite-t-elle une préparation spéciale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une préparation spéciale n'est pas nécessaire, mais un état de calme est recommandé." } }, { "@type": "Question", "name": "Comment maintenir les effets de la tDCS ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des exercices cognitifs et un suivi psychologique peuvent aider à maintenir les effets." } }, { "@type": "Question", "name": "Comment se déroule une séance de tDCS ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Une séance de tDCS dure généralement 20 à 30 minutes avec des électrodes placées sur le cuir chevelu." } }, { "@type": "Question", "name": "À quelle fréquence la tDCS est-elle administrée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La fréquence varie, mais elle est souvent administrée plusieurs fois par semaine." } }, { "@type": "Question", "name": "La tDCS est-elle combinée à d'autres traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée en complément de thérapies psychologiques ou médicamenteuses." } }, { "@type": "Question", "name": "Quels sont les objectifs du traitement par tDCS ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les objectifs incluent l'amélioration de l'humeur, de la cognition et la réduction de la douleur." } }, { "@type": "Question", "name": "La tDCS est-elle efficace pour tous ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'efficacité varie d'une personne à l'autre en fonction de divers facteurs individuels." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la tDCS ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent inclure des irritations cutanées ou des maux de tête." } }, { "@type": "Question", "name": "La tDCS peut-elle aggraver des conditions existantes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, elle peut aggraver des troubles neurologiques préexistants." } }, { "@type": "Question", "name": "Quels signes doivent alerter après une séance ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs persistantes, des vertiges ou des troubles de la vision doivent alerter." } }, { "@type": "Question", "name": "La tDCS est-elle sans risque pour tous ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle n'est pas recommandée pour les personnes avec des implants médicaux ou des troubles épileptiques." } }, { "@type": "Question", "name": "Comment gérer les effets indésirables de la tDCS ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets indésirables doivent être signalés à un professionnel de santé pour évaluation." } }, { "@type": "Question", "name": "Quels facteurs augmentent les risques de tDCS ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de troubles neurologiques ou psychiatriques peuvent augmenter les risques." } }, { "@type": "Question", "name": "L'âge influence-t-il l'efficacité de la tDCS ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge peut influencer l'efficacité, les jeunes répondant souvent mieux au traitement." } }, { "@type": "Question", "name": "Les médicaments affectent-ils la tDCS ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent interférer avec les effets de la tDCS, nécessitant une évaluation." } }, { "@type": "Question", "name": "Le stress impacte-t-il la tDCS ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un niveau de stress élevé peut diminuer l'efficacité de la tDCS." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches suggèrent que des prédispositions génétiques peuvent influencer la réponse à la tDCS." } } ] } ] }

Sources (10000 au total)

Poisoning with central stimulant drugs: an observational study from Oslo, Norway.

The use of central stimulant drugs causes significant morbidity. We describe poisonings with central stimulant drugs and compare the different central stimulants concerning combinations with other dru... Among the 1131 cases of acute poisoning with central stimulant drugs at the outpatient clinic, amphetamine was involved in 808 (71.4%), cocaine in 252 (22.3%) methylenedioxymethamphetamine (MDMA) in 1... Amphetamine was the most common central stimulant drug involved in acute poisoning in Oslo, often combined with opioids and benzodiazepines....

Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke.

Repetitive peripheral magnetic stimulation (rPMS) is a non-invasive treatment method that can penetrate to deeper structures with painless stimulation to improve motor function in people with physical... To assess the effects of rPMS for improving activities of daily living and functional ability in people after stroke.... We searched the Cochrane Stroke Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL), in the Cochrane Library; MEDLINE; Embase; the Cumulative Index to Nursing and Allied... We included randomised controlled trials (RCTs) conducted to assess the therapeutic effect of rPMS for people after stroke. The following comparisons were eligible for inclusion: 1) active rPMS only c... Two review authors independently assessed studies for inclusion in the review. The same review authors assessed methods and risk of bias, undertook data extraction, and evaluated the certainty of the ... We included four trials (three parallel-group RCTs and one cross-over trial) involving a total of 139 participants. This result was unchanged from the review published in 2019. Blinding of participant... There is insufficient evidence to permit the drawing of any conclusions about routine use of rPMS for people after stroke. Additional trials with large sample sizes are needed to provide robust eviden...

Photobiomodulation at 830 nm Stimulates Migration, Survival and Proliferation of Fibroblast Cells.

Photobiomodulation (PBM) promotes diabetic wound healing by favoring cell survival and proliferation. This study aimed to investigate the potential of PBM in stimulating cellular migration, viability,... The study explored the in vitro effects of near infrared (NIR) light on cell viability (survival) and proliferation as well as the presence of TGF-β1, phosphorylated TGF-β receptor type I (pTGF-βR1) a... Results show a significant increase in cellular migration in wounded models, and increased viability and proliferation in irradiated cells compared to their respective controls. An increase in the pre... These findings show that PBM at 830 nm using a fluence of 5 J/cm...

Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts.

Billions of individuals worldwide suffer from periodontal disease, an inflammatory disease that results in hard-tissue and soft-tissue destruction. A viable therapeutic option to treat periodontal dis... Human gingival fibroblasts (HGFs) obtained from ATCC were cultured per the manufacturer's recommendation. The functional activity of cannabinoid receptors was measured using ACTOne (cAMP)-based CB1R a... Cannabidivarin (CBVN or CBDV) (EC... The effective inhibition of IL-1β-stimulated production of PGE2 and cytokines by the pCB in HGFs suggests that targeting the endocannabinoid system may lead to the development of therapeutic strategie...

Real-World Evidence of Transcutaneous Afferent Patterned Stimulation for Essential Tremor.

Transcutaneous afferent patterned stimulation (TAPS) is a prescription, wrist-worn device-delivered, non-invasive neuromodulation therapy for treatment of hand tremor in patients with essential tremor... Demographics were summarized from TAPS prescriptions received from the patient's healthcare provider. Therapy usage and effectiveness were analyzed from device logs, which included tremor measurements... A total of 321 patients (average age 71 years, 32% female) met the criteria for this analysis, 216 of whom had tremor measurements available for analysis and 69 of whom completed the survey. Total usa... Real-world evidence is consistent with prior clinical trials and confirms TAPS provides safe and effective tremor control for many patients with ET. Future work assessing multi-year safety and effecti...